Tilson Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$395K Buy
1,556
+4
+0.3% +$932 0.11% 65
2026
Q1
$379K Sell
1,552
-7
-0.4% -$1.63K 0.11% 64
2025
Q4
$323K Sell
1,559
-129
-8% -$25.5K 0.1% 67
2025
Q3
$313K Buy
1,688
+138
+9% +$23.6K 0.1% 64
2025
Q2
$237K Buy
1,550
+13
+0.8% +$2K 0.09% 66
2025
Q1
$255K Buy
1,537
+31
+2% +$4.85K 0.1% 65
2024
Q4
$218K Buy
1,506
+42
+3% +$6.51K 0.09% 70
2024
Q3
$237K Buy
+1,464
New +$233K 0.1% 66
2024
Q2
Sell
-1,593
Closed -$252K 53
2024
Q1
$252K Buy
1,593
+88
+6% +$14K 0.14% 64
2023
Q4
$236K Buy
1,505
+47
+3% +$7.21K 0.15% 59
2023
Q3
$227K Buy
+1,458
New +$241K 0.18% 57
2023
Q2
Sell
-1,522
Closed -$236K 43
2023
Q1
$236K Buy
1,522
+5
+0.3% +$807 0.19% 54
2022
Q4
$268K Buy
+1,517
New +$262K 0.23% 52

Other funds holding JNJ

Tilson Financial Group's JNJ Position: Q2 2026 in Review

Tilson Financial Group increased its Johnson & Johnson (JNJ) stake by 0.26% in Q2 2026, buying an estimated $932 and bringing the position to 1,556 shares worth $395K. The position accounts for 0.11% of the portfolio, ranked #65.

Tilson Financial Group first reported a position in JNJ in Q4 2022 and has held it in 13 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Tilson Financial Group held 1,556 shares of Johnson & Johnson worth $395K as of Q2 2026.
  • Tilson Financial Group bought 4 Johnson & Johnson shares in Q2 2026, an estimated $932.
  • Johnson & Johnson made up 0.11% of Tilson Financial Group's portfolio in Q2 2026, its #65 holding.
  • Tilson Financial Group first reported a position in Johnson & Johnson in Q4 2022 and has held it in 13 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Tilson Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.